|
Kabra Drugs Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
76.39 Cr.
|
P/BV
|
2.94
|
Book Value (Rs.)
|
10.96
|
|
52 Week High/Low (Rs.)
|
33/11
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 19.76 | 7.15 | 0.00 | 0.00 | 0.00 |
| Total Income From Operations | 19.76 | 7.15 | 0.00 | 0.00 | 0.00 |
| Purchase of Traded Goods | 33.05 | 6.75 | 0.00 | 0.00 | 0.00 |
| Increase/Decrease in Stocks | -16.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employees Cost | 0.36 | 0.38 | 0.25 | 0.19 | 0.14 |
| Depreciation | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 |
| Other Expenses | 0.84 | 0.53 | -0.01 | 0.34 | 0.25 |
| Total Expenses | 17.74 | 7.67 | 0.25 | 0.54 | 0.40 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2.03 | -0.52 | -0.25 | -0.54 | -0.40 |
| Other Income | 0.18 | 0.02 | 0.64 | 0.00 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | 2.21 | -0.50 | 0.39 | -0.54 | -0.40 |
| P/L Before Exceptional Items & Tax | 2.21 | -0.50 | 0.39 | -0.54 | -0.40 |
| P/L Before Tax | 2.21 | -0.50 | 0.39 | -0.54 | -0.40 |
| Tax | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L After Tax from Ordinary Activities | 1.84 | -0.50 | 0.39 | -0.54 | -0.40 |
| Net Profit/Loss For the Period | 1.84 | -0.50 | 0.39 | -0.54 | -0.40 |
| | | | | | |
| Equity Share Capital | 23.71 | 23.71 | 23.71 | 10.08 | 10.08 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.77 | -0.21 | 0.21 | -0.53 | -3.94 |
| Diluted EPS (Rs.) | 0.77 | -0.21 | 0.21 | -0.53 | -3.94 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.77 | -0.21 | 0.21 | -0.53 | -3.94 |
| Diluted EPS (Rs.) | 0.77 | -0.21 | 0.21 | -0.53 | -3.94 |
| | | | | | |
| PBITOE Margin (%) | 10.25 | -7.21 | N.A | N.A | N.A |
| PBTE Margin (%) | 11.15 | -6.99 | N.A | N.A | N.A |
| PBT Margin (%) | 11.15 | -6.99 | N.A | N.A | N.A |
| PAT Margin (%) | 9.29 | -6.99 | N.A | N.A | N.A |
